Skip to content

ENhanced Recovery in CHildren Undergoing Surgery

Assessing Effectiveness and Implementation of a Perioperative Enhanced Recovery Protocol for Children Undergoing Gastrointestinal Surgery

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04060303
Acronym
ENRICH-US
Enrollment
597
Registered
2019-08-19
Start date
2020-07-01
Completion date
2024-11-06
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis

Keywords

Pediatric Surgery, Implementation, Quality Improvement, Enhanced Recovery Protocols, Gastrointestinal Surgery

Brief summary

The institution of perioperative Enhanced Recovery Protocols (ERPs) has been found to decrease hospital length of stay, in-hospital costs, and complications among adult surgical populations but data in pediatric populations are lacking. The Assessing Effectiveness and Implementation of a Perioperative Enhanced Recovery Protocol for Children Undergoing Gastrointestinal Surgery, which has the short title "ENhanced Recovery In CHildren Undergoing Surgery (ENRICH-US)," study is a multicenter, pragmatic, prospective study, using a stepped wedge cluster randomized controlled trial design. The study is designed to test the adoption, effectiveness, and generalizability of a newly developed, 21-element ERP for children undergoing elective gastrointestinal surgery.

Detailed description

The purpose of this study is to learn more about the clinical effectiveness and to examine obstacles to implementing a Perioperative Enhanced Recovery Protocol (ERP) in pediatric surgery. ERPs are evidence-based interventions that have been developed among adult surgical populations, but implementation of ERPs and data in pediatric populations are lacking. To address this need, we have designed a multicenter, prospective study entitled ENhanced Recovery In CHildren Undergoing Surgery (ENRICH-US). This study is designed to test the adoption, effectiveness, and generalizability of a pediatric specific 21-element ERP intervention for children recovering from surgery compared with usual care. All other peri-operative care in this study will not be modified from usual care pathways, including medications. The basic elements of the ENRICH-US intervention are very similar to the elements of most adult ERPs and include perioperative counseling and education, mindfulness training, maintenance of euvolumia through limited perioperative fasting and limited intraoperative fluid resuscitation, early enteral intake, early mobilization, limited opioid use, and non-routine use of surgical drains and tubes. Elements span the preadmission and pre-, intra-, and post-operative phases of care. The concurrent use of these integrative healthcare interventions results in a markedly improved patient care experience that minimizes the physiologic stress of surgery and hastens recovery. These ERPs have been found to decrease hospital length of stay, in-hospital costs, complications, and help patients recover sooner after surgery. Though each ERP element is independently simple, implementation of the combined elements likely will require substantial redesign of the systems and processes of care to assure a high level of coordination among surgery, anesthesia, and nursing clinicians. This prospective study involves multiple sites and uses a stepped-wedge, cluster-randomized, controlled study design of the ENRICH protocol in pediatric patients undergoing elective GI surgery. The cluster-randomized trial design is ideally suited for pragmatic intervention implementation. A hybrid, type 2 study design will be used with equal focus on evaluating the effectiveness and the implementation. The study will optimize implementation using the National Implementation Research Network's five Active Implementation Frameworks (AIFs), which identify competency, organization, and leadership as drivers of implementation and empower team collaboration and facilitate rapid-cycle evaluation. The five AIFs used as key tools to achieve high-fidelity and sustainable implementation will include patient-stakeholder input in all steps of the improvement process and a Learning Collaborative (LC) with rapid-cycle data feedback. The study, by taking place in the setting where patients receive usual clinical care by usual clinicians, using data primarily from existing data sources (e.g., EHR), having minimal eligibility criteria, and recruiting all eligible pediatric patients undergoing GI surgery delivery, fulfills most of the pragmatic qualities to understand the real-world performance and implications of the intervention. The nature of this trial does not allow for subjects (patients or clinicians) to be blinded. The study will enroll patients at 18 US hospitals ("sites") that participate in the Pediatric Surgery Research Collaborative (PedSRC), a cooperative group of pediatric surgeons and researchers committed to performing clinical research in pediatric surgery. All sites offer comprehensive, inpatient, pediatric services, including surgical services. The PedSRC represents one of the largest pediatric surgical networks for collaboration and research. The 18 sites will be randomly assigned to one of three clusters for the stepped wedge design with each cluster, in turn, being randomly assigned to an intervention start period. Given that many sites have already initiated some ERP elements, a study design that randomizes sites or patients to a control arm without any ERP elements is not feasible. The stepped-wedge design was selected, in part, to ease the practical challenges of concurrently coordinating training and data collection across the 18 sites. The ENRICH-US study provides a unique opportunity to accelerate, yet evaluate the adoption of ERP elements for pediatric GI patients, thus improving surgical care for this high-risk population by rapidly incorporating ERPs into practice, using the five AIFs. This study will serve as a model for future pediatric surgical quality improvement implementation efforts. Clinicians, staff, and patient advocates participated only as part of the implementation Learning Collaborative and interviews. These individuals were not enrolled as study participants and therefore do not appear in enrollment, Participant Flow, Baseline Characteristics, or Outcome Measures. Clarification of Study Participants: ENRICH-US used a stepped-wedge, cluster-randomized design in which clinical sites (18) were the units of assignment. Participants are counted under the study phase active at their site at the time of surgery; thus Baseline (248), Implementation (156), and Sustainability (193) reflect exposure groups rather than cluster membership. All 597 pediatric patients who completed consent/assent were enrolled. Learning Collaborative clinicians, staff, and patient advocates participated only in implementation activities/interviews, were not enrolled research participants, were not randomized, and did not contribute demographic, clinical, or PRO data. Therefore, they are not included in Enrollment, Participant Flow, Baseline Characteristics, Outcome Measures, or Adverse Events.

Interventions

PROCEDUREPerioperative surgical care

The ENRICH-US Protocol includes perioperative counseling and education, maintaining euvolumia through limited perioperative fasting and limited intraoperative fluid resuscitation, early enteral intake and mobilization, limited use of opioids, and non-routine use of surgical drains and tubes. Elements span the pre-, intra-, and post-operative experience for patients and involve care coordination among surgery, anesthesia, and nursing providers. Though individually simple, the concomitant implementation of the combined elements results in a markedly improved patient care experience that mitigates the physiologic stress of surgery and hastens recovery.

Sponsors

Northwestern University
Lead SponsorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

A stepped-wedge, cluster-randomized study design will be used in which the participating sites will be randomly assigned to one of three clusters with each cluster, in turn, being randomly assigned to an intervention start period.

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Pediatric patients ages 10-18 * Undergoing elective (non-emergency) gastrointestinal/colorectal surgical procedures

Exclusion criteria

* Children undergoing emergent/urgent gastrointestinal/colorectal surgical procedures * Patients/families who cannot read and write English or Spanish

Design outcomes

Primary

MeasureTime frameDescription
Length of Stay (LOS)During hospitalization, up to a maximum of 14 days.Measured in days from surgery to discharge

Secondary

MeasureTime frameDescription
Prolonged LOS (>6 Days)Up to 30 days postoperatively. Baseline (Pre-Implementation) Phase: January 2019 - February 2021. Implementation Phase: March 2021 - October 2022. Sustainability Phase: November 2022 - December 2023.Binary variable derived from LOS; \> 6 days = Yes.
Time to Regular DietUp to 30 days postoperatively. Baseline (Pre-Implementation) Phase: January 2019 - February 2021. Implementation Phase: March 2021 - October 2022. Sustainability Phase: November 2022 - December 2023.Days from surgery until first documented tolerance of regular diet in EHR
Intraoperative Fluid UseDuring surgery (intraoperative period).Total volume of intraoperative crystalloid fluid administered, as abstracted from the anesthesia record.
Opioid Use During Hospitalization (MME/Day)During the index hospitalization, from admission through discharge.Average daily opioid use during hospitalization, converted to morphine milligram equivalents (MME/day).
Opioid Prescribed at DischargeAt hospital discharge.Number of participants who were prescribed an opioid medication at the time of hospital discharge.
Surgical Complications (Any)During hospitalization, up to a maximum of 14 days.Composite of surgical, infectious, pulmonary, vascular, neurologic, and renal complications; each participant counted once per category.
Multiple Complications (> 1)During hospitalization, up to a maximum of 14 days.Participants experiencing \> 1 distinct postoperative complication.
30-day ReadmissionUp to 30 days postoperatively. Baseline (Pre-Implementation) Phase: January 2019 - February 2021. Implementation Phase: March 2021 - October 2022. Sustainability Phase: November 2022 - December 2023.Any unplanned hospital readmission within 30 days of discharge after index surgery. Events were abstracted from medical records and categorized as yes/no. Values are reported by study phase as number and percentage of participants readmitted.
Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Global Health Scale (Preoperative)Preoperative assessment within 30 days before surgery.Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Global Health T-score before surgery. The PROMIS Pediatric Global Health Scale (PGH-7) is a validated, standardized patient-reported outcome measure assessing overall physical, mental, and social health in children and adolescents. Scores are reported as T-scores standardized to the U.S. pediatric population, with a mean of 50 and standard deviation of 10. Possible scores typically range from approximately 20 to 80. Higher T-scores indicate better global health. The PROMIS Pediatric Global Health T-score was assessed preoperatively within 30 days prior to surgery and summarized by study phase.
Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Global Health (Postoperative)Postoperative assessment at 2-4 weeks after surgery.The PROMIS Pediatric Global Health Scale (PGH-7) is a validated, standardized patient-reported outcome measure assessing overall physical, mental, and social health in children and adolescents. Scores are reported as T-scores standardized to the U.S. pediatric population, with a mean of 50 and standard deviation of 10, and a typical range of approximately 20 to 80. Higher T-scores indicate better global health. The PROMIS Pediatric Global Health T-score was assessed postoperatively at 2-4 weeks after surgery and summarized by study phase.
Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Pain Interference (Preoperative)Preoperative assessment within 30 days before surgery.The PROMIS Pediatric Pain Interference Scale is a validated patient-reported outcome measure assessing the extent to which pain interferes with physical, emotional, and social functioning in children and adolescents. Scores are reported as standardized T-scores with a mean of 50 and standard deviation of 10, with a typical range of approximately 30 to 80. Higher T-scores indicate greater pain interference (worse outcome). Pain interference T-scores were assessed preoperatively within 30 days prior to surgery and summarized by study phase.
Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Pain Interference (Postoperative)Postoperative assessment at 2-4 weeks after surgery.The PROMIS® Pediatric Pain Interference Scale is a validated patient-reported outcome measure assessing the extent to which pain interferes with physical, emotional, and social functioning in children and adolescents. Scores are reported as standardized T-scores with a mean of 50 and standard deviation of 10, with a typical range of approximately 30 to 80. Higher T-scores indicate greater pain interference (worse outcome). Pain interference T-scores were assessed postoperatively at 2-4 weeks after surgery and summarized by study phase.

Countries

United States

Participant flow

Recruitment details

This was a stepped-wedge, cluster-randomized trial with 18 clinical sites assigned to 3 randomized sequences (6 sites per seq.). Each sequence progressed through Baseline (usual care), Implementation and Sustainability phases at different calendar times according to the prespecified roll-out. Participants reported by the phase active at their site at time of surgery. Learning Collaborative personnel were not research participants and do not contribute to Participant Flow, Outcome Measures or AEs

Pre-assignment details

Sites (clusters) were randomized into 3 sequences (6 sites/sequence) and crossed from Baseline to Implementation to Sustainability per the prespecified roll-out. Participants were enrolled continuously according to surgery dates.

Baseline characteristics

Characteristic
Age at surgery (years)15.2 Years
STANDARD_DEVIATION 2.1
Age, Continuous15 Years
Race/Ethnicity, Customized
Black or African American
24 Participants
Race/Ethnicity, Customized
Hispanic
15 Participants
Race/Ethnicity, Customized
Non-Hispanic White
122 Participants
Race/Ethnicity, Customized
Other (Asian, multiracial, unknown)
56 Participants
Sex: Female, Male
Female
79 Participants
Sex: Female, Male
Male
77 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 2480 / 1560 / 193
other
Total, other adverse events
24 / 24819 / 15620 / 193
serious
Total, serious adverse events
0 / 2480 / 1560 / 193

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026